Daily vs Intermittent Antituberculosis Therapy for Pulmonary Tuberculosis in Patients With HIV: A Randomized Clinical Trial

IMPORTANCE: The benefit of daily over thrice-weekly antituberculosis therapy among HIV-positive patients with pulmonary tuberculosis (TB) who are receiving antiretroviral therapy remains unproven. OBJECTIVE: To compare the efficacy and safety of daily, part-daily, and intermittent antituberculosis t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Intern Med
Autors principals: Gopalan, Narendran, Santhanakrishnan, Ramesh Kumar, Palaniappan, Alangudi Natarajan, Menon, Pradeep Aravindan, Lakshman, Sekar, Chandrasekaran, Padmapriyadarsini, Sivaramakrishnan, Gomathi Narayan, Reddy, Devarajulu, Kannabiran, Bhavani Perumal, Agiboth, Hemanth Kumar Kupparam, Krishnamoorthy, Vijay, Rathinam, Sridhar, Chockalingam, Chandrasekar, Manoharan, Tamizhselvan, Ayyamperumal, MahilMaran, Jayanthi, Nalini, Satagopan, Kumar, Narayanan, Ravichandran, Krishnaraja, Raja, Sathiyavelu, Sekar, Kesavamurthy, Bhanu, Suresh, Chandra, Selvachitiram, Murugesan, Arasan, Gunasundari, Susaimuthu, Stella, Rathinam, Prabhakaran, Angamuthu, Prabhakar, Jayabal, Lavanya, Murali, Lakshmi, Ramachandran, Ranjani, Tripathy, Srikanth Prasad, Swaminathan, Soumya
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2018
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885164/
https://ncbi.nlm.nih.gov/pubmed/29507938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2018.0141
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars